Literature DB >> 15336698

Biosynthesis and catabolism of prostaglandin F2alpha (PGF2alpha) are controlled by progesterone in the rat uterus during pregnancy.

M Farina1, M L Ribeiro, C Weissmann, A Estevez, S Billi, C Vercelli, A Franchi.   

Abstract

Myometrial quiescence is a key factor in all species to accomplish a successful gestation. PGs play a crucial role in mediating parturition events, and their synthesis and metabolism are regulated by cyclooxygenases (COXs) and NAD(+)-dependent 15-hydroxy-PG dehydrogenase (PGDH), respectively. Progesterone (P(4)) is the hormone responsible for maintaining uterine smooth muscle quiescence during pregnancy. In this work, we have studied the effect of P(4) on the activity of COXs and PGDH, the uterine enzymes involved in the biosynthesis and metabolism of prostanoids in the rat. We found that during pregnancy PGF(2alpha) production and also protein levels of COX-1 and COX-2 were decreased. The exogenous administration of P(4) significantly inhibited the uterine production of PGF(2alpha) and also the protein level of COX-2. PGF(2alpha), metabolism was assessed by PGDH activity, which resulted high during pregnancy and increased as a result of P(4) administration. These results indicate that PGs levels were negatively modulated by P(4), which could be exerting its effect by increasing PGs metabolism through stimulation on PGDH activity and an inhibition on COX and that is a major mechanism for maintain uterine quiescence in pregnancy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15336698     DOI: 10.1016/j.jsbmb.2004.05.001

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  8 in total

1.  Progestin-Containing Contraceptives Alter Expression of Host Defense-Related Genes of the Endometrium and Cervix.

Authors:  Gabriel A Goldfien; Fatima Barragan; Joseph Chen; Margaret Takeda; Juan C Irwin; Jean Perry; Ruth M Greenblatt; Karen K Smith-McCune; Linda C Giudice
Journal:  Reprod Sci       Date:  2015-01-28       Impact factor: 3.060

2.  Dual effect of nitric oxide on uterine prostaglandin synthesis in a murine model of preterm labour.

Authors:  M Cella; M G Farina; A P Dominguez Rubio; G Di Girolamo; M L Ribeiro; A M Franchi
Journal:  Br J Pharmacol       Date:  2010-10       Impact factor: 8.739

3.  Epidermal growth factor prevents prepartum luteolysis in the rat.

Authors:  M L Ribeiro; J Aisemberg; S Billi; M G Farina; R Meiss; S McCann; V Rettori; M Villalón; A M Franchi
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-23       Impact factor: 11.205

4.  Two-step inhibitory effect of kanzo on oxytocin-induced and prostaglandin F2α-induced uterine myometrial contractions.

Authors:  Genichiro Sumi; Katsuhiko Yasuda; Chiharu Kanamori; Megumi Kajimoto; Akemi Nishigaki; Tomoko Tsuzuki; Hisayuu Cho; Hidetaka Okada; Hideharu Kanzaki
Journal:  J Nat Med       Date:  2014-04-17       Impact factor: 2.343

5.  Species Comparison of the Role of p38 MAP Kinase in the Female Reproductive System.

Authors:  Zaher A Radi; Rosemary A Marusak; Dale L Morris
Journal:  J Toxicol Pathol       Date:  2009-07-07       Impact factor: 1.628

6.  PGF2alpha induced differential expression of genes involved in turnover of extracellular matrix in rat decidual cells.

Authors:  Eduardo A Callegari; Susan Ferguson-Gottschall; Geula Gibori
Journal:  Reprod Biol Endocrinol       Date:  2005-01-11       Impact factor: 5.211

7.  Opposite effects of methanandamide on lipopolysaccharide-induced prostaglandin E2 and F2α synthesis in uterine explants from pregnant mice.

Authors:  Claudia A Vercelli; Julieta Aisemberg; Maximiliano Cella; Ana Inés Salazar; Manuel L Wolfson; Ana M Franchi
Journal:  PLoS One       Date:  2012-07-05       Impact factor: 3.240

8.  Use of urinary 13,14, dihydro-15-keto-prostaglandin F2α (PGFM) concentrations to diagnose pregnancy and predict parturition in the giant panda (Ailuropoda melanolecua).

Authors:  Beth M Roberts; Janine L Brown; David C Kersey; Rebecca J Snyder; Barbara S Durrant; Andrew J Kouba
Journal:  PLoS One       Date:  2018-05-02       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.